Logo

Philogen Collaborates with Johnson&Johnson (J&J)- Novartis and Celgene

Share this
Philogen Collaborates with Johnson&Johnson (J&J)- Novartis and Celgene

Tuba Khan

Philogen Collaborates with Johnson&Johnson (J&J)- Novartis and Celgene

Shots:
  • Philogen collaborates with J&J to discover & develop therapies utilizing Philochem’s technology (a Swizz subsidiary of Philogen) for serious conditions
  • Philogen signs a development and commercialization agreement with Celgene for novel immunomodulatory therapies
  • Philogen collaborates with Novartis for the research and development of immunomodulatory candidates. In 2017 & 2016- Philogen also collaborated with Boehringer Ingelheim (BI) and Pfizer to develop and commercialize DNA-encoded therapies & ADCs for multiple therapy areas respectively
Click Here  read full press release/ article | Ref: Philogen | Image: Twitter

Click Here

Share this article on WhatsApp, LinkedIn and Twitter

We Have a Viewership of 1,00,000 + Views

Join the PharmaShot Family